These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28400969)

  • 1. Antipsychotic prescribing of consultant forensic psychiatrists working in different levels of secure care with patients with schizophrenia.
    Machin A; McCarthy L
    BJPsych Bull; 2017 Apr; 41(2):103-108. PubMed ID: 28400969
    [No Abstract]   [Full Text] [Related]  

  • 2. The Prevalence and Factors Associated With Antipsychotic Polypharmacy in a Forensic Psychiatric Sample.
    Farrell C; Brink J
    Front Psychiatry; 2020; 11():263. PubMed ID: 32528318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with non evidence-based prescribing of antipsychotics.
    Connolly A; Taylor D
    Ther Adv Psychopharmacol; 2014 Dec; 4(6):247-56. PubMed ID: 25489476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An audit of outpatient antipsychotic usage in the three health sectors of Auckland, New Zealand.
    Humberstone V; Wheeler A; Lambert T
    Aust N Z J Psychiatry; 2004 Apr; 38(4):240-5. PubMed ID: 15038803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psychiatrists' decision making and monitoring of antipsychotic prescription for elderly schizophrenia patients].
    Jalenques I; Ortega V; Legrand G; Auclair C
    Encephale; 2016 Apr; 42(2):124-9. PubMed ID: 26796558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.
    Stone-Brown K; Naji M; Francioni A; Myers K; Samarendra H; Mushtaq-Chaudhry H; Heslop S; Sengupta S; Ross CC; Larkin F; Das M
    CNS Spectr; 2016 Feb; 21(1):60-9. PubMed ID: 26726766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes of psychiatrists toward antipsychotic depot medication.
    Heres S; Hamann J; Kissling W; Leucht S
    J Clin Psychiatry; 2006 Dec; 67(12):1948-53. PubMed ID: 17194274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.
    Patel MX; Nikolaou V; David AS
    Psychol Med; 2003 Jan; 33(1):83-9. PubMed ID: 12537039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical practice variations in prescribing antipsychotics for patients with schizophrenia.
    Owen RR; Fischer EP; Kirchner JE; Thrush CR; Williams DK; Cuffel BJ; Elliott CE; Booth BM
    Am J Med Qual; 2003; 18(4):140-6. PubMed ID: 12934949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatrists' attitude to antipsychotic depot treatment in patients with first-episode schizophrenia.
    Heres S; Reichhart T; Hamann J; Mendel R; Leucht S; Kissling W
    Eur Psychiatry; 2011; 26(5):297-301. PubMed ID: 20570493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Checking the plausibility of psychiatrists׳ arguments for not prescribing depot medication.
    Hamann J; Kissling W; Heres S
    Eur Neuropsychopharmacol; 2014 Sep; 24(9):1506-10. PubMed ID: 25037772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the prescribing patterns of antipsychotic medication in a rural England Community Mental Health Team.
    Seshadri M; Elsemary A; Thalitaya MD; Chikodzore L; Nagalingam P
    Psychiatr Danub; 2017 Sep; 29(Suppl 3):524-529. PubMed ID: 28953820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing for personality disorder: qualitative study of interviews with general and forensic consultant psychiatrists.
    Martean L; Evans C
    Psychiatr Bull (2014); 2014 Jun; 38(3):116-21. PubMed ID: 25237521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient, Physician and Organizational Influences on Variation in Antipsychotic Prescribing Behavior.
    Tang Y; Chang CC; Lave JR; Gellad WF; Huskamp HA; Donohue JM
    J Ment Health Policy Econ; 2016 Mar; 19(1):45-59. PubMed ID: 27084793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.
    Latimer EA; Naidu A; Moodie EE; Clark RE; Malla AK; Tamblyn R; Wynant W
    Psychiatr Serv; 2014 Oct; 65(10):1210-7. PubMed ID: 24981557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hidden magnitude of polypharmacy: using defined daily doses and maximum licensed daily doses to measure antipsychotic load.
    Nguyen ML; Sunderland B; Lim S; Hattingh L; Chalmers L
    Int J Clin Pharm; 2019 Dec; 41(6):1642-1651. PubMed ID: 31677120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes towards long-acting depot antipsychotics: a survey of patients, relatives and psychiatrists.
    Jaeger M; Rossler W
    Psychiatry Res; 2010 Jan; 175(1-2):58-62. PubMed ID: 20004980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and delivery of a quality improvement program to reduce antipsychotic polytherapy.
    Gören JL; Beck SE; Mills BJ; Shtasel DL; Dufresne RL
    J Manag Care Pharm; 2010; 16(6):393-401. PubMed ID: 20635830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].
    Brunot A; Lachaux B; Sontag H; Casadebaig F; Philippe A; Rouillon F; Cléry-Melin P; Hergueta T; Llorca PM; Moreaudefarges T; Guillon P; Lebrun T
    Encephale; 2002; 28(2):129-38. PubMed ID: 11972139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Best practices: An initiative to curtail the use of antipsychotic polypharmacy in a state psychiatric hospital.
    Patrick V; Schleifer SJ; Nurenberg JR; Gill KJ
    Psychiatr Serv; 2006 Jan; 57(1):21-3. PubMed ID: 16399958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.